The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin
Abstract
Background— HMGCR (3-Hydroxy-3-methylglutaryl coenzyme A reductase), the direct target of statin inhibition, undergoes alternative splicing of exon 13, which encodes part of the statin-binding domain of the enzyme. We hypothesized that HMGCR alternative splicing might be related to the interindividual variation in plasma low-density lipoprotein cholesterol response to statin treatment. Methods and Results— We measured mRNA expression of both the full-length and the alternatively spliced HMGCR transcript lacking exon 13 ( HMGCRv_1 ) in 170 simvastatin-incubated immortalized lymphocyte cell lines derived from participants in the Cholesterol and Pharmacogenetics (CAP) study who were treated with simvastatin 40 mg/d for 6 weeks. Greater upregulation of HMGCRv_1 in vitro was significantly correlated ( P ≤0.0001) with smaller in vivo reductions of plasma total cholesterol, low-density lipoprotein cholesterol, apoprotein B, and triglycerides and explained 6% to 15% of the variation in their response to treatment. In contrast, no significant relationship was found between expression of the full-length HMGCR transcript and in vivo response. By siRNA knockdown of the full-length transcript, we found that HMGCR enzyme activity measured in cells enriched in HMGCRv_1 was relatively resistant to statin inhibition, consistent with the association of increased alternative splicing with reduced statin response in the CAP study. In addition, we found that a common HMGCR single-nucleotide polymorphism (rs3846662) located within intron 13 was associated with variation in the proportion of HMGCR mRNA that is alternatively spliced. Conclusions— Variation in the production of an HMGCR isoform with reduced statin sensitivity is a determinant of interindividual differences in low-density lipoprotein cholesterol, apolipoprotein B, and triglyceride response to statin treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although cellular phenotyping of LCLs has long been employed to functionalize the molecular impact of genetic variation associated with elevated cholesterol levels2-4, 6, 9, to our knowledge this is the first instance of capitalizing on the inter-individual variation of a cellular phenotype within LCLs to identify novel genes involved in cellular cholesterol homeostasis.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [6]
Citations
Cites
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
Hunt, D., Young, P., Simes, J., Hague, W., Mann, S., Owensby, D., Lane, G., Tonkin, A., & for the LIPID Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00007 · Cited by 226
Research works printed but not linked: 33
- Brousseau ME. Statins, super-statins and cholesterol absorption inhibitors. IDrugs. 2003; 6: 458–463.
- 10.1001/jama.283.22.2935 · doi:10.1001/jama.283.22.2935
- 10.1161/circ.97.15.1446 · doi:10.1161/circ.97.15.1446
- 10.1161/circ.85.4.1555273 · doi:10.1161/circ.85.4.1555273
- 10.1016/j.amjcard.2005.09.134 · DOI · Paper page
- 10.1016/S0002-9149(02)02599-7 · DOI
- 10.1161/circulationaha.107.708388 · DOI · Paper page
- 10.1001/jama.291.23.2821 · DOI · Paper page
- 10.1016/S0167-7799(03)00146-X · DOI
- 10.1126/science.1090100 · DOI · Paper page
- 10.1007/BF02619631 · DOI · Paper page
- 10.1038/204793a0 · DOI · Paper page
- Pressman S, Rotter JI. Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique. Am J Hum Genet. 1991; 49: 467.
- 10.1016/S0021-9258(17)38120-6 · DOI · Paper page
- 10.1016/S0022-2275(20)42793-2 · DOI
- Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: 34.31–0034.0011.
- 10.1161/01.res.0000174563.62625.8e · DOI
- 10.1007/s10038-003-0121-4 · DOI
- 10.1007/s100380200102 · DOI
- 10.1038/sj.ki.5001590 · DOI
- Nikitin AG, Chudakova DA, Spitsina EV, Minushkina LO, Zateishchikov DA, Nosikov VV, Debabov VG. Association of GNB3 gene C825T polymorphism with coronary heart disease [in Russian]. Genetika. 2007; 43: 1129–1133.
- 10.1093/hmg/ddm124 · DOI
- 10.1086/516650 · DOI
- 10.1074/jbc.C200021200 · doi:10.1074/jbc.c200021200
- 10.1038/sj.tpj.6500195 · DOI
- 10.1093/emboj/19.5.819 · DOI · Paper page
- 10.1016/S0021-9258(18)89764-2 · DOI · Paper page
- 10.1007/s100380070017 · doi:10.1007/s100380070017
- Friesen JA, Rodwell VW. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol. 2004; 5: 248.241–248.247.
- 10.1016/S0022-2275(20)32473-1 · doi:10.1016/s0022-2275(20)32473-1
- 10.1021/bi9916325 · DOI
- Aggarwal D, Freake HC, Soliman GA, Dutta A, Fernandez ML. Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism. Lipids Health Dis. 2006; 5: 22.21–22.24.
- 10.1172/JCI117213 · DOI
Cited by
Plasma lipoproteins: genetic influences and clinical implications
Hegele, R. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2481 · Cited by 462
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
Dysregulation of the mevalonate pathway promotes transformation
Clendening, J. W., Pandyra, A., Boutros, P. C., Ghamrasni, S. E., Khosravi, F., Trentin, G. A., Martirosyan, A., Hakem, A., Hakem, R., Jurisica, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910258107 · Cited by 417
Testicular Cancer Survivorship: Research Strategies and Recommendations
Travis, L. B., Beard, C., Allan, J. M., Dahl, A. A., Feldman, D. R., Oldenburg, J., Daugaard, G., Kelly, J. L., Dolan, M. E., Hannigan, R., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq216 · Cited by 294
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function
Gao, F., Ihn, H. E., Medina, M. W., & Krauss, R. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds559 · Cited by 36
Self-citation
Metadata
- Authors
- Medina, M. W., Gao, F., Ruan, W., Rotter, J. I., & Krauss, R. M.
- Affiliations
- From the Children’s Hospital Oakland Research Institute, Oakland (M.W.M., F.G., W.R., R.M.K.), and Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles (J.I.R.), Calif.
- Venue
- Circulation
- Published
- 2008-07-22
- Volume
- 118
- Issue
- 4
- Pages
- 355-362
- ISSN
- 0009-7322
- 1524-4539
- Cited by
- 119
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin. https://app.cochat.ai/papers/10.1161/circulationaha.108.773267
- The paper
- Medina, M. W., Gao, F., Ruan, W., Rotter, J. I., & Krauss, R. M. (2008). Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin. Circulation. https://doi.org/10.1161/circulationaha.108.773267
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.